WHO ICTRP trial

Efficacy and safety of Fecal Microbiota Transplantation (FMT) by gastroscopy in…

ChiCTR2400092799 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2400092799
Public title Efficacy and safety of Fecal Microbiota Transplantation (FMT) by gastroscopy in the treatment of patients with refractory schizophrenia: a randomized, double-blind, placebo-controlled trial
Scientific title Efficacy and safety of Fecal Microbiota Transplantation (FMT) by gastroscopy in the treatment of patients with refractory schizophrenia:
Primary sponsor The Affiliated Brain Hospital, Guangzhou Medical University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase 0
Countries China
Conditions Schizophrenia
Interventions Group A:Subjects will receive intraduodental administration of fecal bacteria by gastroscopy and oral placebo capsule.;Group B:Subjects will receive intraduodental administration of placebo by gastroscopy and oral fecal microbiota…
Registration date Nov 22, 2024
Target size Group A:40;Group B:40;Group C:40
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations